Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Name: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renal-cell-carcinoma

renal cell carcinoma, hereditary leiomyomatosis, renal cell cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 216976
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.